Ipratropium/albuterol inhalation solution is a combination medication used to treat breathing difficulties in people with chronic obstructive pulmonary disease (COPD). It contains two bronchodilators—ipratropium, which relaxes airway muscles by blocking acetylcholine, and albuterol, which stimulates beta-2 receptors to open the airways. Together, they help improve airflow, reduce wheezing, and make breathing easier during flare-ups or daily management.